ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002
January 17, 2023 04:00 ET | AKAMPION
- Lead compound IOS-1002 to be studied as mono and combination therapy in patients with advanced solid tumors- First patients to be enrolled in Q1, 2023 Schlieren (Zurich Area), Switzerland –...
BioMed X Logo
BioMed X and AbbVie Extend Research Collaboration in the US
January 16, 2023 13:00 ET | BioMed X Institute
HEIDELBERG, Germany, Jan. 16, 2023 (GLOBE NEWSWIRE) -- BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie....
Professor Dr. med. Matthias Dobbelstein_cropped
Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board
December 06, 2022 07:30 ET | BiondVax Pharmaceuticals Ltd.
Jerusalem, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing and commercializing...
Multiple Sclerosis Therapeutics Market Size Worth $39.22 Bn by 2027 – The Insight Partners
November 09, 2022 09:12 ET | The Insight Partners
New York, Nov. 09, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners new research study titled "Multiple Sclerosis Therapeutics Market Size, Share, Growth and Forecast to 2027 – COVID-19...
Lyophilized Injectable Drugs Market to hit USD 740 Billion by 2030, says Global Market Insights Inc.
October 11, 2022 06:10 ET | Global Market Insights Inc.
Selbyville, Delaware, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The lyophilized injectable drugs market value is projected to reach USD 740 billion by 2030, according to a new research report by Global...
IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast featuring Amro Albanna, CEO of Aditxt, Inc.
August 02, 2022 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 02, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment...
MicrosoftTeams-image (5).png
Ultra-large Volume Wearable Injectors Market to Surpass Valuation of US$ 6.6 Bn by 2031: TMR Study
June 09, 2022 08:30 ET | Transparency Market Research
Wilmington, Delaware, United States, June 09, 2022 (GLOBE NEWSWIRE) -- The demand analysis of ultra-large volume wearable injectors reiterates the growing trend of subcutaneous routes of...
Monoclonal Antibodies Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
May 12, 2022 05:00 ET | Graphical Research
Pune, India, May 12, 2022 (GLOBE NEWSWIRE) -- The global monoclonal antibodies market size is predicted to witness remarkable growth during the forecast period, due to the rising incidence of...
Call-to-Action Banner of Throne Equity Crowdfunding Campaign
Throne Biotechnologies Launches Equity Crowdfunding to Support Phase 2 Clinical Trials in Type 1 Diabetes and Alopecia Areata
February 28, 2022 09:00 ET | Throne Biotechnologies Inc
PARAMUS, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Throne Biotechnologies, one of the global-leading biotech companies aiming to find a cure for type 1 diabetes, announced the launch of their...
Antibody Therapy Market Revenue to hit $445 Billion by 2028, Says Global Market Insights Inc.
February 22, 2022 03:00 ET | Global Market Insights Inc.
Selbyville, Delaware, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Global antibody therapy market value projected to cross USD 445 billion by 2028, according to a new research report by Global Market...